These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30575391)

  • 1. Carbon Nanoparticles Inhibit the Aggregation of Prion Protein as Revealed by Experiments and Atomistic Simulations.
    Zhou S; Zhu Y; Yao X; Liu H
    J Chem Inf Model; 2019 May; 59(5):1909-1918. PubMed ID: 30575391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How graphene affects the misfolding of human prion protein: A combined experimental and molecular dynamics simulation study.
    Zhu Y; Guo J; Zhang A; Li L; Liu X; Liu H; Yao X
    Environ Res; 2019 Apr; 171():1-10. PubMed ID: 30641367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and Theoretical Insights into the Inhibition Mechanism of Prion Fibrillation by Resveratrol and its Derivatives.
    Li L; Zhu Y; Zhou S; An X; Zhang Y; Bai Q; He YX; Liu H; Yao X
    ACS Chem Neurosci; 2017 Dec; 8(12):2698-2707. PubMed ID: 28817252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Inhibitory Effect of Hydroxylated Carbon Nanotubes on the Aggregation of Human Islet Amyloid Polypeptide Revealed by a Combined Computational and Experimental Study.
    Mo Y; Brahmachari S; Lei J; Gilead S; Tang Y; Gazit E; Wei G
    ACS Chem Neurosci; 2018 Nov; 9(11):2741-2752. PubMed ID: 29986579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation Condition-Structure Relationship of Mouse Prion Protein Fibrils.
    Fridmanis J; Toleikis Z; Sneideris T; Ziaunys M; Bobrovs R; Smirnovas V; Jaudzems K
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid formation characteristics of GNNQQNY from yeast prion protein Sup35 and its seeding with heterogeneous polypeptides.
    Haratake M; Takiguchi T; Masuda N; Yoshida S; Fuchigami T; Nakayama M
    Colloids Surf B Biointerfaces; 2017 Jan; 149():72-79. PubMed ID: 27736724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the early stages of prion protein (PrP) aggregation with atomistic molecular dynamics simulations.
    Collu F; Spiga E; Chakroun N; Rezaei H; Fraternali F
    Chem Commun (Camb); 2018 Jul; 54(57):8007-8010. PubMed ID: 29967919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction Dynamics in Inhibiting the Aggregation of Aβ Peptides by SWCNTs: A Combined Experimental and Coarse-Grained Molecular Dynamic Simulation Study.
    Lin D; Qi R; Li S; He R; Li P; Wei G; Yang X
    ACS Chem Neurosci; 2016 Sep; 7(9):1232-40. PubMed ID: 27441457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide dismutase-1 alters the rate of prion protein aggregation and resulting fibril conformation.
    Ziaunys M; Mikalauskaite K; Veiveris D; Sakalauskas A; Smirnovas V
    Arch Biochem Biophys; 2022 Jan; 715():109096. PubMed ID: 34848178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the influence of carbon nanoparticles on the formation of β-sheet-rich oligomers of IAPP₂₂₋₂₈ peptide by molecular dynamics simulation.
    Guo J; Li J; Zhang Y; Jin X; Liu H; Yao X
    PLoS One; 2013; 8(6):e65579. PubMed ID: 23755253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiment and molecular dynamics simulations reveal proanthocyanidin B2 and B3 can inhibit prion aggregation by different mechanisms.
    Li Q; Zhu Y; Meng X; Tong HHY; Liu H
    J Biomol Struct Dyn; 2024 Mar; 42(5):2424-2436. PubMed ID: 37144732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prion principle and Alzheimer's disease.
    Walker LC; Jucker M
    Science; 2024 Sep; 385(6715):1278-1279. PubMed ID: 39298592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replica Exchange Molecular Dynamics Study of Dimerization in Prion Protein: Multiple Modes of Interaction and Stabilization.
    Chamachi NG; Chakrabarty S
    J Phys Chem B; 2016 Aug; 120(30):7332-45. PubMed ID: 27390876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-Like Characteristics of Polyglutamine-Containing Proteins.
    Pearce MMP; Kopito RR
    Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 28096245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.
    Maïza A; Chantepie S; Vera C; Fifre A; Huynh MB; Stettler O; Ouidja MO; Papy-Garcia D
    FEBS Lett; 2018 Dec; 592(23):3806-3818. PubMed ID: 29729013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
    Sengupta I; Udgaonkar JB
    Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.
    Candelise N; Schmitz M; Da Silva Correia SM; Arora AS; Villar-Piqué A; Zafar S; Llorens F; Cramm M; Zerr I
    Expert Rev Mol Diagn; 2017 Oct; 17(10):897-904. PubMed ID: 28817974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Octapeptide Repeats on Prion Folding and Misfolding.
    Yu KH; Huang MY; Lee YR; Lin YK; Chen HR; Lee CI
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the conformation of human prion protein in ethanol solution using molecular dynamics simulations.
    Xia K; Shen H; Wang P; Tan R; Xun D
    J Biomol Struct Dyn; 2023; 41(12):5872-5881. PubMed ID: 35838152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.